Home 
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.2, p.100-105, 2016
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.2, p.100-105, 2016
Journal info
|
||||
Select Journal
Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.2, p.100-105, 2016 |
||
| Title: Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats | ||
| Author: R. Akcilar, F. E. Kocak, H. Simsek, A. Akcilar, Z. Bayat, E. Ece, H. Kokdasgil | ||
| Abstract: BACKGROUND: To examine the effects of adropin on glucose and lipid metabolism in a rat model of Type 2 diabetes mellitus (T2DM). METHODS: T2DM were established using high-fat diet and streptozocin (STZ; 35 mg/kg/b.w.). Seven days after STZ induction, diabetic rats were randomly treated with adropin (2.1 μg/kg/day intraperitonealy) for 10 days. The study involved the evaluation of biochemical parameters, including blood glucose, total cholesterol (TC), triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT) activities. Additionally, Tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6) and inducible nitric oxide synthase (iNOS) mRNA gene expressions in pancreas tissue were determined by reverse transcription-polymerase chain reaction. RESULTS: The serum levels of insulin and adropin were determined by ELISA. Treatment with adropin showed a significant reduction in blood glucose levels, HbA1c (%), HOMA-IR and increase in HOMA-β, serum insulin levels. In addition, intraperitoneal adropin application can reduce serum levels of TC, TG, LDL-C, and increase level of HDL-C. Adropin also effectively ameliorated the alterations in TNF-α, IL-6 and iNOS mRNA expression. CONCLUSION: The present study indicates that the adropin possesses antidiabetic and antidyslipidemic effects in T2DM (Tab. 2, Fig. 3, Ref. 32). |
||
| Keywords: adropin, type 2 diabetic rat, blood glucose, insulin, high fat diet | ||
| Published online: 24-Jan-2016 | ||
| Year: 2016, Volume: 116, Issue: 2 | Page From: 100, Page To: 105 | |
| doi:10.4149/BLL_2016_020 |
||
|
|
 download file |
|